Sökning: "JNK"
Visar resultat 21 - 25 av 92 avhandlingar innehållade ordet JNK.
21. Cisplatin-induced tumor cell death signaling and potentiation by energy metabolism inhibitors
Sammanfattning : Treatment of cancer is associated with challenges including the tumor development of resistance. By elucidating intracellular signal transduction pathways elicited by therapy it is possible to identify structures and processes crucial for induction of cell death. The aim is to exploit this knowledge to improve treatment strategies. LÄS MER
22. Role of the map kinase pathways in maintenance of the transformed phenotype
Sammanfattning : In order to interfere pharmacologically with tumor growth and metastasis, it is of great importance to understand the status of the signal transduction systems in tumor cells. The effect of various oncogenes on cellular signal transduction events has largely been studied in short term experiments. LÄS MER
23. Inhibition of crucial oncogenes by pharmacologically activated p53
Sammanfattning : The tumor suppressor p53 is a transcriptional factor which is frequently inactivated in cancer, either by point mutations or by its negative regulators, such as Mdm2 and MdmX. Reactivation of p53 by small molecules is a promising strategy to treat cancer. LÄS MER
24. The role of the deubiquitinating enzyme CYLD and its substrate BCL-3 in solid tumors
Sammanfattning : The tumor suppressor CYLD and the proto-oncogene BCL-3 are known to be deregulated in various cancer types. The molecular background of how these genes participate in carcinogenesis is not fully understood. LÄS MER
25. Signal Transduction by Proline-Rich Tyrosine Kinase Pyk2
Sammanfattning : The proline-rich tyrosine kinase (Pyk2) together with focal adhesion kinase (FAK) define a family of non-receptor protein tyrosine kinases that are regulated by diverse stimuli. Activation of Pyk2 has been implicated in multiple signaling events, including modulation of ion channels, activation of MAP kinase cascades and apoptotic cell death. LÄS MER